Cyclopentanamine

Cyclopentanamine

SCHEMBL5824045

NC1CCCC1.O=C(NC1CCCC1)c1cccc2[nH]c(-c3n[nH]c4ncc(-c5cncc6ccccc56)cc34)nc12

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
RET P07949 6/20 0.68
CDK1 P06493 11/20 0.55
KDR P35968 8/20 0.55
ERBB2 P04626 4/20 0.45
DYRK1A Q13627 3/20 0.42
WNT1 P04628 3/20 0.42
CLK2 P49760 1/20 0.42
CLK3 P49761 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
PDPK1 O15530 1/20 0.40
TGFBR1 P36897 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5822024 0.96 RET (0.72) RETCDK1KDRERBB2DYRK1A
SCHEMBL4034588 0.96 RET (0.72) RETCDK1KDRERBB2DYRK1A
SCHEMBL13797812 0.96 RET (0.71) RETCDK1KDRERBB2DYRK1A
SCHEMBL4039375 0.93 RET (0.76) RETCDK1KDRERBB2DYRK1A
SCHEMBL13797811 0.91 RET (0.72) RETCDK1KDRERBB2DYRK1A
SCHEMBL13797808 0.89 RET (0.68) RETCDK1KDRERBB2DYRK1A
SCHEMBL4034114 0.83 CDK1 (0.76) RETCDK1KDRERBB2DYRK1A
SCHEMBL4033912 0.83 CDK1 (0.72) RETCDK1KDRERBB2DYRK1A
SCHEMBL4034123 0.82 CDK1 (0.59) RETCDK1KDRERBB2DYRK1A
SCHEMBL4039622 0.82 RET (0.76) RETCDK1KDRERBB2DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006130673-A1 3-BENZOIMIDAZOLYL-PYRAZOLOPYRIDINES USEFUL IN TREATING KINASE DISORDERS JANSSEN PHARMACEUTICA, N.V. (BE) 2006-12-07 WO disclosed